NEW YORK, Feb. 12, 2016 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC is
investigating potential claims on behalf of purchasers of the
securities of DaVita Healthcare Partners Inc. ("DaVita" or "the
Company") (NYSE: DVA). Such investors are advised to contact
Peretz Bronstein or his Investor
Relations Analyst, Yael Hurwitz at
info@bgandg.com or 212-697-6484.
This investigation concerns whether DaVita and certain of its
officers and/or directors have violated the Federal Securities Laws
under the Securities Exchange Act of 1934 (the "Exchange
Act").
On February 11, 2016, post-market,
DaVita released that the U.S. Attorney's Office for the Northern
District of Texas it had sent a
Civil Investigative Demand (CID) about a False Claims Act
investigation into allegations that it submitted false claims to
the government for prescription drug reimbursement dating back to
January 1, 2006.
Following this news, the DaVita stock dropped as much as
$1.99, or 3.18%, to $60.58 per share on February 11, 2016 post-market.
If you are aware of any facts relating to this investigation, or
purchased shares of DaVita, you can assist this investigation by
visiting the firm's website: http://www.bgandg.com/#!dva/btad0. You
can also contact Peretz Bronstein or
his Investor Relations Analyst, Yael
Hurwitz of Bronstein, Gewirtz & Grossman, LLC at
212-697-6484 or via email info@bgandg.com. Those who inquire
by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-davita-healthcare-partners-inc-dva-300219364.html
SOURCE Bronstein, Gewirtz & Grossman, LLC